Paroxetine Hydrochloride
C19H20FNO3·HCl
365.83
Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-. ()-(3S,4R)-4-(p-Fluorophenyl)-3-[(3,4-methylenedioxy)phenoxy]methyl]piperidine hydrochloride [78246-49-8]. Hemihydrate 374.83 » Paroxetine Hydrochloride is anhydrous or contains one-half molecule of water of hydration. It contains not less than 98.5 percent and not more than 102.0 percent of C19H20FNO3·HCl, calculated on the anhydrous and solvent-free basis.
Packaging and storage
Preserve the anhydrous form in tight containers. Preserve the hemihydrate form in well-closed containers. Store at controlled room temperature.
Labeling
Label it to indicate whether it is the anhydrous or the hemihydrate form. Label it to indicate with which impurity tests the article complies.
USP Reference standards 11
USP Paroxetine Hydrochloride RS . USP Paroxetine System Suitability Mixture A RS. USP Paroxetine Related Compound B RS . USP Paroxetine Related Compound C RS . USP Paroxetine Related Compound E Mixture RS . USP Paroxetine Related Compound F RS . USP Paroxetine Related Compound G RS .
Identification
A:
Infrared Absorption 197M
Test specimen
Dissolve a suitable portion of Paroxetine Hydrochloride in a solution of water in isopropyl alcohol (1 in 10), heat to 70 to dissolve, recrystallize, and dry the residue under vacuum at 50 for 3 hours.
Standard specimen:
a similar preparation of USP Paroxetine Hydrochloride RS.
B:
A solution (1 in 100) in a mixture of methanol and water (1:1) meets the requirements of the test for Chloride 191.
Water, Method I 921:
not more than 1.5% for the anhydrous form and between 2.2% and 2.8% for the hemihydrate form.
Residue on ignition 281:
not more than 0.1%.
Heavy metals, Method II 231:
0.002%.
Limit of related compound C
Mobile phase
Prepare a mixture of n-hexane, absolute alcohol, water, and trifluoroacetic acid (900:100:2:2). Make adjustments if necessary (see System Suitability under Chromatography 621).
Diluent:
a mixture of absolute alcohol and n-hexane (1:1).
Standard solution
Dissolve an accurately weighed quantity of USP Paroxetine Related Compound C RS, and dilute quantitatively, and stepwise if necessary, with Diluent to obtain a solution having a known concentration of about 0.1 mg per mL.
Test solution
Transfer about 125 mg of Paroxetine Hydrochloride, accurately weighed, to a 25-mL volumetric flask, dissolve in and dilute with Diluent to volume, and mix.
System suitability solution
Dilute known volumes of the Test solution and the Standard solution with Diluent to obtain a solution having known concentrations of about 0.1 mg per mL each of Paroxetine Hydrochloride and of USP Paroxetine Related Compound C RS.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 295-nm detector and a 4.6-mm × 25-cm column that contains packing L51. The flow rate is about 1.0 mL per minute, and the column temperature is maintained at 30. Chromatograph the System suitability solution, and record the peak responses as directed for Procedure: the relative retention times for paroxetine and paroxetine related compound C are 1.0 and about 0.6, respectively; the resolution, R, between paroxetine and paroxetine related compound C is not less than 2.0; and the tailing factor for paroxetine related compound C is not greater than 2.5. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the relative standard deviation for replicate injections is not more than 10.0% for the paroxetine related compound C.
Procedure
Separately inject equal volumes (about 5 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of paroxetine related compound C in the portion of Paroxetine Hydrochloride taken by the formula:
100(CS / CT)(rU / rS)
in which CS is the concentration, in mg per mL, of USP Paroxetine Related Compound C RS in the Standard solution; CT is the concentration, in mg per mL, of Paroxetine Hydrochloride on the anhydrous basis in the Test solution; and rU and rS are the peak areas for paroxetine related compound C in the Test solution and the Standard solution, respectively: not more than 0.1% of paroxetine related compound C is found.
Limit of 1-methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine
Solution A
Dissolve about 30 g of sodium perchlorate in about 900 mL of water. Add 3.5 mL of phosphoric acid and 2.4 mL of triethylamine. Dilute with water to 1000 mL, and mix. Adjust with phosphoric acid or triethylamine to a pH of 2.0.
Solution B:
acetonitrile, filtered and degassed.
Diluent:
a mixture of water and acetonitrile (4:1).
Mobile phase
Use variable mixtures of Solution A and Solution B as directed for Chromatographic system. Make adjustments to either solution as necessary (see System Suitability under Chromatography 621).
Standard solution
Dissolve an accurately weighed quantity of USP Paroxetine Related Compound E Mixture RS, and dilute quantitatively, and stepwise if necessary, with Diluent to obtain a solution having a known concentration of about 42 ng per mL of 1-methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine.
Test solution
Transfer about 420 mg of Paroxetine Hydrochloride, accurately weighed, to a 10-mL volumetric flask, and dissolve in about 7 mL of Diluent with sonication. Dilute with Diluent to volume, and mix.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 242-nm detector and a 4.0-mm × 25-cm column that contains packing L1. The column temperature is maintained at 30. The flow rate is about 1.5 mL per minute. The chromatograph is programmed as follows.
Procedure
Separately inject equal volumes (about 75 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of 1-methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in the portion of Paroxetine Hydrochloride taken by the formula:
100(CS / CT)(ri / rS)I
in which CS is the concentration, in mg per mL, of USP Paroxetine Related Compound E Mixture RS in the Standard solution; CT is the concentration, in mg per mL, of Paroxetine Hydrochloride on the anhydrous basis in the Test solution; ri and rS are the peak areas for 1-methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine obtained from the Test solution and the Standard solution, respectively; and I is the fraction, by weight, of 1-methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in USP Paroxetine Related Compound E Mixture RS: not more than 0.0001% of 1-methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine is found.
Chromatographic purity
[noteOn the basis of the synthetic route, perform either Test 1 or Test 2. Test 2 is recommended if paroxetine related compound F or paroxetine related compound G is a potential related compound.]
test 1
Solution A
Prepare a filtered and degassed mixture of water, tetrahydrofuran, and trifluoroacetic acid (180:20:1).
Solution B
Prepare a filtered and degassed mixture of acetonitrile, tetrahydrofuran, and trifluoroacetic acid (180:20:1).
Mobile phase
Use variable mixtures of Solution A and Solution B as directed for Chromatographic system. Make adjustments if necessary (see System Suitability under Chromatography 621).
Diluent:
a mixture of water and tetrahydrofuran (9:1).
Standard solution
Dissolve an accurately weighed quantity of USP Paroxetine Hydrochloride RS, and dilute quantitatively, and stepwise if necessary, with Diluent to obtain a solution having a known concentration of about 1 µg per mL.
System suitability solution
Dissolve, by sonication if necessary, a suitable quantity of USP Paroxetine System Suitability Mixture A RS in Diluent to obtain a solution having a known concentration of about 1 mg per mL.
Test solution
Transfer about 25 mg of Paroxetine Hydrochloride, accurately weighed, to a 25-mL volumetric flask, dissolve in 20 mL of Diluent, sonicate, dilute with Diluent to volume, and mix.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 285-nm detector and a 4.6-mm × 25-cm column that contains packing L7. The flow rate is about 1 mL per minute. The column temperature is maintained at 40. The chromatograph is programmed as follows.
Table 1
Procedure
Separately inject equal volumes (about 20 µL) of the Standard solution, the Test solution, and the Diluent into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of each impurity in the portion of Paroxetine Hydrochloride taken by the formula:
100(CS / CT)(rU / rS)
in which CS is the concentration, in mg per mL, of USP Paroxetine Hydrochloride RS in the Standard solution; CT is the concentration, in mg per mL, of Paroxetine Hydrochloride on the anhydrous basis in the Test solution; rU is the peak area of each impurity in the Test solution, excluding the peaks obtained from the chromatogram of the Diluent; and rS is the peak area of paroxetine obtained from the Standard solution.
test 2
Phosphate buffer
Dissolve 3.4 g of monobasic potassium phosphate and 3.4 g of tetrabutylammonium hydrogen sulfate in 1.0 L of water.
Solution A
Prepare a filtered and degassed mixture of Phosphate buffer and acetonitrile (98:2).
Solution B
Prepare a filtered and degassed mixture of Phosphate buffer and acetonitrile (6:4).
Mobile phase
Use variable mixtures of Solution A and Solution B as directed for Chromatographic system. Make adjustments if necessary (see System Suitability under Chromatography 621).
Diluent:
a mixture of Phosphate buffer and acetonitrile (9:1).
Standard solution
Dissolve an accurately weighed quantity of USP Paroxetine Hydrochloride RS, USP Paroxetine Related Compound B RS, USP Paroxetine Related Compound F RS, and USP Paroxetine Related Compound G RS in Diluent, and dilute quantitatively, and stepwise if necessary, with Diluent to obtain a solution having known concentrations of about 4 µg per mL, 10 µg per mL, 10 µg per mL, and 4 µg per mL, respectively.
Identification solution
Dissolve an accurately weighed quantity of USP Paroxetine Hydrochloride RS, USP Paroxetine Related Compound B RS, USP Paroxetine Related Compound F RS, and USP Paroxetine Related Compound G RS in Diluent to obtain a solution having known concentrations of about 2 mg per mL, 10 µg per mL, 10 µg per mL, and 4 µg per mL, respectively.
Test solution
Transfer about 25 mg of Paroxetine Hydrochloride, accurately weighed, to a 50-mL volumetric flask, dissolve in and dilute with Diluent to volume, and mix.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 210-nm detector and a 3.9-mm × 15-cm column that contains packing L1. The flow rate is about 1.0 mL per minute. The chromatograph is programmed as follows.
Table 2
Procedure
Separately inject equal volumes (about 25 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of paroxetine related compound B, paroxetine related compound F, and paroxetine related compound G in the portion of Paroxetine Hydrochloride taken by the formula:
100(CS / CT)(ri / rS)
in which CS is the concentration, in mg per mL, of the appropriate USP Reference Standard in the Standard solution; CT is the concentration, in mg per mL, of Paroxetine Hydrochloride on the anhydrous basis in the Test solution; and ri and rS are the peak areas for the corresponding impurity in the Test solution and the Standard solution, respectively. Calculate the percentage of any unspecified impurity in the portion of Paroxetine Hydrochloride taken by using the formula given above, in which ri is the peak area for any unspecified impurity in the Test solution; and rS is the peak area of paroxetine in the Standard solution.
Assay
Acetate buffer
Prepare a 0.05 M solution of ammonium acetate in water, adjust with glacial acetic acid to a pH of 4.5, mix, and filter.
Mobile phase
Prepare a filtered and degassed mixture of Acetate buffer, acetonitrile, and triethylamine (70:30:1). [noteThe Acetate bufferacetonitriletriethylamine ratio can be varied between 70:40:1 and 75:25:1 to meet the system suitability requirements.] Adjust with glacial acetic acid to a pH of 5.5. Make adjustments if necessary (see System Suitability under Chromatography 621).
System suitability solution
Dissolve suitable quantities of USP Paroxetine Related Compound B RS and USP Paroxetine Hydrochloride RS in water to obtain a solution having known concentrations of about 0.5 mg of each USP Reference Standard per mL.
Standard preparation
Dissolve an accurately weighed quantity of USP Paroxetine Hydrochloride RS in water, and dilute quantitatively, and stepwise if necessary, with water to obtain a solution having a known concentration of about 0.5 mg per mL.
Assay preparation
Transfer about 50 mg of Paroxetine Hydrochloride, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with water to volume, and mix.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 295-nm detector and a 4.6-mm × 25-cm column that contains packing L13. The flow rate is about 1 mL per minute. Chromatograph the System suitability solution, and record the peak responses as directed for Procedure: the resolution, R, between paroxetine related compound B and paroxetine is not less than 2.0; the tailing factor for the paroxetine peak is not more than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%. [noteFor information purposes, the approximate relative retention times are about 0.9 for paroxetine related compound B and 1.0 for paroxetine.]
Procedure
Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of C19H20FNO3·HCl in the portion of Paroxetine Hydrochloride taken by the formula:
100(CS / CU)(rU / rS)
in which CS is the concentration, in mg per mL, of paroxetine hydrochloride in the Standard preparation; CU is the nominal concentration, in mg per mL, of Paroxetine Hydrochloride in the Assay preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 3214
Pharmacopeial Forum: Volume No. 33(5) Page 932
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|